TERESITA SAYLOR, M.D.
Legal Medicine in LONG BEACH, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
TERESITA SAYLOR, M.D. filed 2,545 Medicare Part D claims in 2023 as a Legal Medicine in LONG BEACH, California, prescribing 78% generic.
- 3K
- Part D claims, 2023
- 78%
- generic prescribing
- $119.46
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
TERESITA SAYLOR, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
2,545 Top 13% higher than 87% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
What does the federal data show about TERESITA SAYLOR, M.D.?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in California
How Legal Medicine compares to other specialties among California providers
Legal Medicine share within California
Legal Medicine is one of the more visible NUCC categories in California
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Legal Medicine (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Legal Medicine ABMS/AOA estimate
Est. board-certified rate (Legal Medicine) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Legal Medicine US NPIs
Specialty board-certified rate — Legal Medicine estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
TERESITA SAYLOR, M.D. appears in the CMS NPPES registry as a Legal Medicine provider holding M.D. credentials at 4056 ORANGE AVE, LONG BEACH, CA, 90807, with a listed phone of (562) 424-3328. NPI 1780631309 was issued on 05/28/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SAYLOR most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 2,545 prescription claims written by this provider, covering 44 Medicare beneficiaries and totaling roughly $219K in drug spend, split 22% brand-name and 78% generic by claim count, with an opioid prescribing rate of 1.7%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Legal Medicine is a narrow specialty nationwide, with 1,067 enrolled providers across 51 states and an average of 2,821 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1780631309 |
|---|---|
| Specialty | Legal Medicine |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 05/28/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm TERESITA SAYLOR, M.D.'s current license status, disciplinary history, and board certifications with the Medical Board of California in California before relying on this page for a clinical or care decision.
How we sourced this profile
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for TERESITA SAYLOR, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$119
Largest payer
Boehringer Ingelheim Pharmaceuticals, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — California MBC 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to TERESITA SAYLOR, M.D.. To verify TERESITA SAYLOR, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
22% brand-name claims vs 78% generic, on 2,545 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 2,569
- Total Day Supply
- 36,834
- Brand vs Generic
- 22% brand / 78% generic
- Brand Drug Cost
- $122K
- Generic Drug Cost
- $96K
- Opioid Claims
- 43 (1.7% rate)
- Antibiotic Claims
- 124
Patient Demographics
- Average Patient Age
- 71.1 years
- Avg HCC Risk Score
- 8.74
- Gender Split
- 45% female / 55% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What TERESITA SAYLOR, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Atorvastatin Calcium
Atorvastatin Calcium
143 claims
- Ipratropium-Albute…
Ipratropium-Albuterol
118 claims
- Pantoprazole Sodium
Pantoprazole Sodium
111 claims
- Amlodipine Besylate
Amlodipine Besylate
94 claims
- Sodium Chloride
Sodium Chloride
74 claims
- Sevelamer Carbonate
Sevelamer Carbonate
67 claims
- Insulin Lispro Kwi…
Insulin Lispro Kwikpen U-100
66 claims
- Metoprolol Tartrate
Metoprolol Tartrate
65 claims
| Drug | Claims |
|---|---|
| Atorvastatin Calcium | 143 |
| Ipratropium-Albuterol Ipratropium/Albuterol Sulfate | 118 |
| Pantoprazole Sodium | 111 |
| Amlodipine Besylate | 94 |
| Sodium Chloride 0.9 % Sodium Chloride | 74 |
| Sevelamer Carbonate | 67 |
| Insulin Lispro Kwikpen U-100 Insulin Lispro | 66 |
| Metoprolol Tartrate | 65 |
| Levothyroxine Sodium | 64 |
| Famotidine | 62 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Legal Medicine Overview
How TERESITA SAYLOR, M.D. fits within the Legal Medicine landscape nationally.
TERESITA SAYLOR, M.D.'s 2,545 claims are below the specialty average of 2,821.
Nearby Legal Medicine Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as SAYLOR.
Compare Legal Medicine nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore California
Frequently Asked Questions
What is TERESITA SAYLOR, M.D.'s specialty? ▼
How much does TERESITA SAYLOR, M.D. prescribe under Medicare Part D? ▼
Where is TERESITA SAYLOR, M.D. located? ▼
What is TERESITA SAYLOR, M.D.'s NPI number? ▼
Does TERESITA SAYLOR, M.D. prescribe more brand-name or generic drugs? ▼
Does TERESITA SAYLOR, M.D. prescribe opioids? ▼
How many Legal Medicine providers are there in the US? ▼
What drugs does TERESITA SAYLOR, M.D. prescribe most often? ▼
Does TERESITA SAYLOR, M.D. accept Medicare? ▼
How can I verify TERESITA SAYLOR, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology